首页 > 市场调查报告书 > 医疗设备

导管

神经血管器材市场规模、份额和成长分析（按疾病病理、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1898530

神经血管器材市场规模、份额和成长分析（按疾病病理、最终用户和地区划分）－2026-2033年产业预测

Neurovascular Devices Market Size, Share, and Growth Analysis, By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes), By End User (Hospitals And Surgical Centers, Ambulatory Care Centers), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，神经血管器械市场规模将达到 40.1 亿美元，到 2025 年将达到 43.6 亿美元，到 2033 年将达到 83.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 8.5%。

神经血管和心血管疾病发生率的上升是全球神经血管器械需求的主要驱动因素。人口老化和人们对神经血管疾病认识的提高预计将进一步推动此类器械的销售成长。微创手术的日益普及、医疗设备技术的进步以及对早期诊断的重视，预计也将成为进一步推动市场扩张的因素。此外，急性缺血性脑中风的广泛发生也为该领域的供应商创造了新的机会。然而，高成本、监管要求严格以及发展中地区可及性有限等挑战可能会阻碍市场成长。併发症和器械故障带来的风险也可能对未来神经血管器械的需求产生不利影响。

神经血管器械市场驱动因素

不健康的生活方式和选择导致神经血管疾病的发生率不断上升，使得越来越多的患者罹患中风和脑动脉瘤等疾病。这一令人担忧的趋势凸显了有效神经血管治疗设备的迫切需求，因为医疗系统正努力应对这些疾病日益沉重的负担。因此，神经血管疾病发病率的上升催生了对先进医疗技术和设备的强劲需求，这些技术和设备旨在有效管理和治疗这些疾病。推动该领域创新解决方案的倡议，体现了人们致力于改善患者预后并应对神经血管疾病挑战的更广泛承诺。

限制神经血管器械市场的因素

由于这些先进技术高成本，神经血管器械市场面临巨大的限制。虽然已开发国家或许能够负担这些费用，但对于预算往往更为紧张的开发中国家的医疗机构而言，这却构成了严峻的挑战。这种经济障碍会限制患者获得必要的神经血管治疗，并阻碍医疗机构在最需要这些器械的地区采用和实施这些创新设备。因此，这种限制因素会影响患者的整体治疗效果以及经济欠发达地区神经血管疾病治疗的有效性。

神经血管器材市场趋势

神经血管器械市场正呈现出显着的微创器械发展趋势，这主要得益于消费者对能够更快康復、减少併发症的手术方式日益增长的偏好。这种转变促使製造商不断创新和改进产品，专注于开发能够在不影响疗效的前提下简化手术流程的技术。随着医疗机构将病患安全和舒适度置于首位，能够辅助微创手术的神经血管器械的需求预计将会成长。该领域的持续进步和创新有望推动销售成长，这也凸显了製造商调整产品开发策略以适应不断变化的市场动态的重要性。

脑动脉瘤
- 栓塞线圈
- 裸露可拆卸线圈
- 绝缘可剥离线圈
- 血流分流装置
- 颅内支架
- 微导管
- 导管导引线
缺血性中风
- 血栓清除装置
- 吸力/吸力装置
- 血管勒除器
- 微导管
- 导管导引线
- 球囊导管
颈动脉狭窄
- 颈动脉支架
- 栓塞保护装置
- 球囊导管
动静脉畸形和瘻管
- 液态栓塞剂
- 闭塞球囊导管
- 微导管
其他疾病状况

全球神经血管器械市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

医院及手术中心
门诊治疗中心
研究和学术机构

全球神经血管器材市场规模（按地区划分）及复合年增长率（2026-2033 年）

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Acandis GmbH（Germany）
Asahi Intecc Co. Ltd.（Japan）
Imperative Care Inc.（United States）
Integer Holdings Corporation（United States）
Johnson & Johnson（United States）
Medtronic plc（Ireland）
MicroPort Scientific Corporation（China）
Penumbra Inc.（United States）
Perflow Medical Ltd.（Israel）
Rapid Medical（Canada）
Stryker Corporation（United States）
Terumo Corporation（Japan）
WL Gore & Associates（United States）
Penumbra, Inc.（United States）（duplicate）
Siemens Healthineers AG（Germany）
Boston Scientific Corporation（United States）
InspireMD, Inc.（Israel）

结论与建议

简介目录

Product Code: SQMIG35A2777

Neurovascular Devices Market size was valued at USD 4.01 Billion in 2024 and is poised to grow from USD 4.36 Billion in 2025 to USD 8.37 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The escalating incidence of neurological and cardiovascular disorders is significantly driving the global demand for neurovascular devices. An increasing aging population and heightened awareness of neurovascular conditions are anticipated to further enhance sales of these devices. The growing preference for minimally invasive procedures, technological advancements in medical devices, and a focus on early diagnosis are additional factors expected to propel the market's expansion. Furthermore, the widespread occurrence of acute ischemic strokes presents new opportunities for suppliers in this sector. However, challenges such as high device costs, stringent regulatory requirements, and limited accessibility in developing regions may hinder market growth. The associated risks of complications and device failures could also negatively impact the future demand for neurovascular devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Devices Market Segments Analysis

Global Neurovascular Devices Market is segmented by Disease Pathology, End User and region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysms, Ischemic Strokes, Carotid Artery Stenosis, Arteriovenous Malformation & Fistulas and Other Disease Pathologies. Based on End User, the market is segmented into Hospitals And Surgical Centers, Ambulatory Care Centers and Research Laboratories and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Devices Market

The rising prevalence of neurovascular diseases, driven by unhealthy lifestyle choices and habits, has led to an increased number of individuals affected by conditions such as strokes and cerebral aneurysms. This alarming trend highlights a critical need for effective neurovascular devices, as healthcare systems strive to address the growing burden of these disorders. Consequently, the heightened incidence of neurovascular issues is creating a strong demand for advanced medical technologies and devices designed to manage and treat these conditions effectively. The push for innovative solutions in this sector reflects a broader commitment to enhancing patient outcomes and addressing the challenges posed by neurovascular diseases.

Restraints in the Neurovascular Devices Market

The Neurovascular Devices market faces a significant constraint due to the high costs associated with these advanced technologies. While such expenses may be manageable for healthcare institutions in developed nations, they pose a considerable challenge for facilities in developing countries where budgets are often tight. This financial barrier can restrict access to essential neurovascular treatments, hindering the ability of healthcare providers to adopt and implement these innovative devices in regions that would benefit from them the most. Consequently, this limitation could impact overall patient outcomes and the effectiveness of neurovascular care in less affluent areas.

Market Trends of the Neurovascular Devices Market

The Neurovascular Devices market is witnessing a significant trend towards the development of minimally invasive devices, driven by the increasing consumer preference for procedures that facilitate quicker recovery and reduced complications. This shift is prompting manufacturers to innovate and enhance their offerings, focusing on technologies that streamline surgical interventions without compromising efficacy. As healthcare providers prioritize patient safety and comfort, the demand for neurovascular devices capable of supporting minimally invasive procedures is expected to grow. Continuous advancements and innovations in this domain are likely to propel sales, underscoring the importance for manufacturers to align their product development strategies with these evolving market dynamics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Studies
Customer And Buying Criteria Analysis
Trade Analysis

Global Neurovascular Devices Market Size by Disease Pathology & CAGR (2026-2033)

Market Overview
Cerebral Aneurysms
- Embolic Coils
- Bare Detachable Coils
- Coated Detachable Coils
- Flow Diversion Devices
- Intracranial Stents
- Microcatheters
- Guidewires
Ischemic Strokes
- Clot Retriever Devices
- Suction & Aspiration Devices
- Vascular Snares
- Microcatheters
- Microguidewires
- Balloon Catheters
Carotid Artery Stenosis
- Carotid Artery Stents
- Embolic Protection Devices
- Balloon Catheters
Arteriovenous Malformation & Fistulas
- Liquid Embolic Agents
- Occlusion Balloon Catheters
- Microcatheters
Other Disease Pathologies

Global Neurovascular Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals And Surgical Centers
Ambulatory Care Centers
Research Laboratories and Academic Institutes

Global Neurovascular Devices Market Size & CAGR (2026-2033)

North America (Disease Pathology, End User)
- US
- Canada
Europe (Disease Pathology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Disease Pathology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Disease Pathology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Disease Pathology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Acandis GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imperative Care Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perflow Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rapid Medical (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WL Gore & Associates (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States) (duplicate)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments